載入...
Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored
Background. Tacrolimus is the primary immunosuppressive drug used in kidney transplant patients. Replacing brand name products with generics is a controversial issue that we studied after a Chilean Ministry of Health mandate to implement such a switch. Methods. Forty-one stable Prograf (Astellas) re...
Na minha lista:
| 發表在: | J Transplant |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi Publishing Corporation
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5299171/ https://ncbi.nlm.nih.gov/pubmed/28246556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5646858 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|